Incannex Healthcare (IXHL) Intangibles (2022 - 2023)
Incannex Healthcare (IXHL) posted Intangibles of $52.7 million for Q2 2023, little changed sequentially from $52.7 million in Q4 2022.
Incannex Healthcare (IXHL) Intangibles (2022 - 2023) Analysis & Trends
Incannex Healthcare has reported Intangibles for 2 years, with the latest figure at $52.7 million in Q2 2023.
- Quarterly Intangibles changed N/A year-over-year to $52.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $52.7 million (changed N/A YoY) and the FY2023 annual result came in at $52.7 million, changed N/A from the prior year.
- Intangibles was little changed at $52.7 million in Q2 2023 per IXHL's latest filing, from $52.7 million in the prior quarter.
- Over five years, Intangibles peaked at $52.7 million in Q4 2022 and troughed at $52.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 1.12 Bn |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 52.72 Mn |
| Dec 31, 2022 | 52.72 Mn |